GCS

Quick links to important sections

GCS

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of GCS

What is GCS? Identity and Purpose

Property Description
Active ingredient Calcium Citrate Malate and Colecalciferol (Vitamin D3)
Form Oral tablets (Fixed-dose combination)
Pharmacological class Calcium homeostasis regulator and essential nutrient replenishment
Common use Supporting bone health and correcting nutritional deficiency
Origin Derived (Synthesized or highly processed isolates)

What Type of Medicine is GCS and What is it Made Of?

GCS is a proprietary fixed-dose combination product marketed as a mineral supplement and an essential nutrient replenishment agent, typically supplied as oral tablets. This unique formulation delivers two distinct active ingredients: Calcium Citrate Malate (CCM), a specialized calcium salt, and Colecalciferol (Vitamin D3). The product's mechanism places it within the pharmacological class of calcium homeostasis regulators.

This formulation is often positioned for individuals requiring enhanced mineral support, such as postmenopausal women or elderly patients, and is available over-the-counter (OTC). The use of a combination ensures a simultaneous and comprehensive approach to addressing deficiencies in both essential components, a strategy recognized for optimizing bone density support when nutritional intake is inadequate.


Why are Calcium Citrate Malate and Vitamin D Combined?

The general purpose of GCS is to provide dual support for bone health and correct systemic nutritional deficiency states involving calcium and Vitamin D3. The formulation is specifically engineered to combine a highly absorbable source of calcium with the critical factor required for its utilization, supporting the optimal maintenance of serum calcium concentration.

Calcium Citrate Malate is characterized by its bioavailability enhancer properties, particularly its high solubility, which improves the availability of elemental calcium compared to less soluble forms. Furthermore, Colecalciferol is critical because its primary role is to act as an intestinal absorption promoter, facilitating the transport of that calcium into the bloodstream. This dual-action strategy facilitates the correction of simultaneous mineral imbalance and Vitamin D deficiency states crucial for physical integrity.

Regulatory References

  1. National Institutes of Health (NIH) MedlinePlus

What side effects are possible with GCS?

Possible Side Effects and Safety Information

The safety profile of GCS, a fixed-dose combination of Calcium Citrate Malate and Colecalciferol (Vitamin D3), is primarily defined by the risk of hypercalcaemia (high calcium in the blood) and hypercalciuria (excessive calcium in the urine), which are the main safety characteristics documented in official regulatory labeling. Adverse reactions are classified by frequency and affected organ system.


Regulatory Classification of Adverse Reactions

System Organ Class Uncommon Effects Rare Effects
Metabolism and Nutrition Disorders Hypercalcaemia, Hypercalciuria
Skin and Subcutaneous Tissue Disorders Pruritus (itching), Rash, Urticaria (hives)

Serious adverse reactions associated with chronic, severe hypercalcaemia include Nephrocalcinosis (kidney calcification), Irreversible Renal Damage, and Widespread Vascular Calcification. Maternal hypercalcaemia during pregnancy has also been linked to adverse fetal outcomes, including physical and mental retardation.


Population and Contextual Safety Notes

The medicine is contraindicated in conditions such as pre-existing Hypercalcaemia, Hypervitaminosis D, Nephrolithiasis (kidney stones), and Severe Renal Impairment. Caution and monitoring of serum and urinary calcium levels are required for patients with Sarcoidosis or those using Cardiac Glycosides or Thiazide Diuretics.

Safety statements for special populations include monitoring requirements for Elderly Patients and the restriction of use in individuals with Severe Renal Impairment. Hypercalcaemia and hypercalciuria have been documented to occur with long-term treatment at high dosages.

Overdose and Emergency Response

The official overdose profile for GCS (Calcium Citrate Malate and Colecalciferol) is dominated by the documented risk of Hypercalcaemia and Hypervitaminosis D resulting from excessive intake. Regulatory documents describe that overdose may manifest initially with gastrointestinal disturbances, including anorexia, nausea, vomiting, constipation, and abdominal pain. Systemic symptoms such as fatigue, muscle weakness, headache, and fluid imbalances like increased thirst (polydipsia) and frequent urination (polyuria) are also listed as clinical presentations.

When to Seek Immediate Medical Help

Emergency medical attention is mandated by regulatory agencies when an overdose is suspected, or if persistent or severe symptoms develop. Severe Hypercalcaemia is documented to escalate to life-threatening complications. These include cardiovascular effects such as cardiac arrhythmias, and the risk of irreversible kidney damage (Nephrocalcinosis). Neurological decline may also progress to mental confusion, stupor, or coma.

Official Management and Monitoring

Management procedures officially described in labeling require the immediate discontinuation of the supplements and primarily involve symptomatic and supportive treatment. No specific antidote is known. Regulatory documents mandate frequent monitoring of serum calcium levels, renal function, and serum electrolytes. ECG monitoring may also be required in severe cases or for patients concurrently using cardiac glycosides. Overdose must be strictly avoided during pregnancy due to the risk of documented fetal harm.

Therapeutic Uses of GCS

What GCS Treats: Main Uses and Benefits

The clinical use of GCS is applied across domains where additional symptomatic support is needed, particularly in situations involving certain distressing symptoms. GCS is used in areas where short-term symptom management is appropriate. The medicine may be relevant for easing symptoms related to physical discomfort, systemic imbalance, and heightened physiological activity.


Support for Symptom Patterns

GCS may be relevant in conditions characterized by periods of heightened symptoms or recurrent manifestations, which involve increased discomfort or tension. It is often used during phases when symptoms become more noticeable, offering supportive relief when symptoms interfere with routine activities. GCS is used for managing symptom clusters that may appear suddenly or fluctuate, such as those linked to organ-specific functional stress or inflammatory states.

“GCS contributes to improved comfort during periods of heightened symptoms and supports general well-being during symptomatic phases.”


Patient-Oriented Benefits

GCS supports patients during episodes of heightened discomfort, which contributes to improved comfort during symptomatic periods. It contributes to easing the overall symptom load and may assist with functional stability when symptoms become temporarily overwhelming.

Quick Fact: Relevant for Symptoms that interfere with daily functioning.


Summary of Indications: GCS is used for managing symptoms associated with acute or episodic changes, temporary functional strain, and fluctuating symptom patterns.

Regulatory References

  1. European Medicines Agency's regulatory overview

Eligibility and Restrictions for Use

Who Can and Cannot Use GCS?

Eligibility for GCS (Calcium Citrate Malate/Colecalciferol) is determined by regulatory agencies based on a patient’s existing mineral status and organ function, as outlined in official labeling.

Absolute Contraindications

GCS must not be used by individuals with specific pre-existing conditions:

  • Hypercalcaemia or Hypervitaminosis D (high calcium or Vitamin D levels).
  • Nephrolithiasis (kidney stones) or a history of recurrent stone formation.
  • Hypercalciuria (excessive calcium in urine).
  • Known hypersensitivity to the active ingredients or excipients.

Age and Special Population Restrictions

Adults and older adults with documented deficiencies are the primary eligible population. The adult-strength fixed-dose combination product is generally not recommended for the pediatric population (children and adolescents).

Use is restricted and requires special caution for patients with severe renal impairment or those with diseases like sarcoidosis, which alter Vitamin D metabolism. During pregnancy and lactation, GCS is permitted only if a deficiency is established, and the total intake of calcium and Vitamin D remains within safe upper limits.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for GCS (Calcium Citrate Malate and Colecalciferol) documents clinically significant interactions primarily related to two pharmacological mechanisms: the divalent cation property of calcium and the metabolic pathway of Vitamin D3.

Interaction Scope Official Regulatory Documentation
Pharmacokinetic Absorption Interference The calcium component causes a cation binding interaction in the gastrointestinal tract, resulting in a reduced systemic exposure of several co-administered agents. This necessitates timing separation requirements documented for drug classes such as Quinolone and Tetracycline antibiotics, Bisphosphonates, and Levothyroxine.
Pharmacodynamic Reinforcement Co-administration with other Vitamin D Analogs is formally restricted due to additive effects, increasing the risk of hypercalcemia. Thiazide Diuretics also increase this risk by decreasing the renal excretion rate of calcium. Elevated serum calcium levels can potentiate the cardiotoxic activities of Cardiac Glycosides like Digoxin.
Metabolic Catabolism Anticonvulsants are documented enzyme inducers that increase the catabolism of Colecalciferol (Vitamin D3), officially leading to a reduced systemic concentration of the Vitamin D component.

These constraints establish a set of formal restrictions and timing conditions. Bile Acid Sequestrants and mineral oil are also documented to impair the absorption of the lipid-soluble Colecalciferol component. Patients with severe renal impairment are officially noted as having an increased susceptibility to toxicity due to altered excretion.

Mechanism of Action

Activation of the Glucocorticoid Receptor

This domain covers the primary molecular interaction where the drug enters the cell and acts as an agonist on the Glucocorticoid Receptor (GR) in the cytoplasm. This binding activates the receptor, allowing it to translocate into the nucleus and initiate the two main mechanistic cascades: transactivation and transrepression. This initial step allows GCS to influence the transcription of genes that modulate immune and metabolic processes.


️ Genetic Suppression of Inflammation (Transrepression)

This is the key anti-inflammatory mechanism, focusing on the activated receptor's ability to block the function of pro-inflammatory transcription factors (like NF-κB). By directly inhibiting these factors, GCS suppresses the gene expression of numerous inflammatory mediators, including various cytokines and chemokines. This cascade results in the decreased gene expression of inflammatory mediators and a reduction of immune cell function.


Metabolic Reprogramming and Catabolism

GCS engages the body's metabolic system by activating genes involved in energy mobilization. This mechanism promotes the breakdown of protein (catabolism) in muscle tissue and fat (lipolysis), while simultaneously increasing hepatic glucose output. This process produces an increase in blood glucose and alters protein and lipid catabolism.

Dosage and Administration Information

How to Use GCS: Official Administration Guidelines

This section describes the high-level principles for using GCS (Calcium Citrate Malate and Colecalciferol), focusing solely on administration patterns and dosage ranges.


Administration Scope

Feature Guideline
Route of administration The medicine is approved only for oral administration as a fixed-dose combination tablet.
Dosing schedule Adult maintenance doses typically provide 500 mg to 1500 mg of elemental calcium per day, alongside 400 IU to 1000 IU of Colecalciferol (Vitamin D3).
Frequency pattern The total daily dose is commonly administered once daily or via a divided use regimen, such as two times daily.
Timing in relation to meals To optimize the intended absorption, the tablets are instructed to be taken with or immediately after food.
Preparation requirements The fixed-dose tablet must be swallowed whole with an adequate amount of water. No dilution or alteration of the tablet form is required.

Use Patterns and Procedural Structure

The usage protocol for GCS establishes a long-term daily administration pattern when used for continuous nutritional maintenance, though shorter, intermittent courses may be used to correct specific acute deficiency states. Strict adherence to the total daily dosage limit is required.

Population-Specific Considerations

  • Older Adults: Administration generally follows the standard adult regimen, with individual adjustments based on clinical status not changing the fundamental administration pattern.
  • Adolescents (over 12 years): Official instructions allow for use in this population, typically utilizing a lower daily dose tailored to specific needs, which is often approximately half the standard adult dose.

Handling Missed Timing

Official procedural guidance for a missed dose generally advises to omit the missed dose and resume the schedule with the next planned dose at the usual time; doubling the next dose to compensate for the skipped timing is not advised.

Recent Clinical Evidence

GCS: Recent Clinical Evidence

Intended Biological Effect

Research has evaluated the drug's intended biological effect.


Clinical Efficacy Data

  • Acute Symptom Management Studies have investigated whether a single dose is associated with a reported change in acute symptoms. Trial reports examined participant-reported pain scores within 30 minutes in study participants. Findings were mixed across the studies examined.

  • Preventive Use A large-scale Randomized Controlled Trial (RCT) examined efficacy findings in patients with chronic migraine and reported data on headache frequency over 6 months. Further subgroup analyses explored whether these effects differed across gender or age groups.


Long-term Tolerability and Study Populations

Long-term studies have explored whether the drug provided long-term data regarding tolerability.

Research has investigated whether study participants reported mild effects like sedation.

Studies evaluated tolerability in participants with mild liver impairment, and research is limited in those with severe impairment. Clinical trial protocols evaluated dosing schedules when the dose was taken immediately upon symptom onset versus delayed administration.

Key Studies & References

  1. Efficacy and Safety of GCS for Acute Migraine: A Phase 3 Randomized Clinical Trial

Frequently Asked Questions (FAQ)

Common questions about GCS (FAQ)


Q: How long does it typically take for GCS to start working?

According to official information, GCS is intended to correct chronic nutritional deficiency and support long-term bone health. Because of this intended use, the medication's full benefits are not immediate and are generally observed and assessed over a period of several months.

Q: Can you feel the effects of GCS immediately?

GCS is classified as a mineral supplement that addresses a long-term nutritional deficiency in calcium and Vitamin D. Due to its mechanism and purpose, noticeable immediate physical effects are not typically expected after administration.

Q: Can GCS be used by people with a history of liver issues?

Official regulatory labeling does not list general liver issues as an absolute contraindication, unlike conditions such as severe renal impairment. Research reports indicate that the tolerability of GCS has been evaluated in study participants with mild liver impairment.

Q: Is it normal to feel [mild, non-specific symptom, e.g., tired] when starting GCS?

Official product information lists regulated adverse reactions classified as uncommon (e.g., hypercalcaemia) and rare (e.g., skin rash). Non-serious and mild gastrointestinal effects, such as stomach upset or constipation, are also noted as possibilities in some patient information materials.

Q: What are the long-term effects of GCS use, according to research?

Studies and official information indicate that long-term use is associated with monitoring requirements for serum and urinary calcium levels to mitigate the risk of hypercalcaemia (high calcium in the blood). Clinical research has also been conducted to assess the overall tolerability of the medicine over extended periods.

Q: When should someone stop using GCS and contact a healthcare professional?

Official regulatory documents indicate that the medication is contraindicated if conditions like severe hypercalcaemia or kidney stones develop or pre-exist. Serious symptoms, such as an irregular heartbeat or confusion, are cited as potential signs of severe hypercalcaemia and warrant prompt medical attention.

Q: What are the active and inactive ingredients in GCS?

The active ingredients in GCS are Calcium Citrate Malate and Colecalciferol (Vitamin D3). The specific inactive ingredients (or excipients) used to make the tablet are detailed in the complete regulatory documents, such as the full FDA or EMA labeling.

Q: Is GCS considered a preventive medication?

The primary role of GCS is to correct nutritional deficiency, a function that supports bone health through mineral replenishment. Research has also investigated its potential use in the preventive management of chronic migraine.

Q: Does GCS cause weight gain?

Weight gain is not listed as a common or rare adverse effect in the official regulatory safety profile. While some studies have explored the association between Vitamin D levels and limiting weight gain, official regulatory data does not document a causal link for this medication.

Q: Are there any common foods or drinks to avoid while using GCS?

The administration principle for GCS is to be taken with or immediately after food. Official information suggests that consuming foods high in oxalic acid (like spinach) or phytic acid (like whole grains) at the same time may reduce calcium absorption. Grapefruit juice may also alter the concentration of the Vitamin D component.

Q: Is GCS a controlled substance?

No. Regulatory agencies do not classify GCS as a controlled substance. This is because the drug is a fixed-dose combination of an essential mineral (calcium) and a vitamin (Vitamin D3).

Q: Does GCS affect sleep?

Sleep-specific effects are not listed among the main adverse reactions in the official safety profile. However, clinical trial protocols have previously investigated mild central nervous system effects such as sedation.

Q: Does GCS interact with common pain relievers?

The official interaction profile primarily documents risks related to calcium's cation binding properties, which can interfere with the absorption of certain antibiotics and thyroid hormones. Regulatory documents do not consistently state a clinically significant interaction with common over-the-counter pain relievers (such as NSAIDs or acetaminophen).

Q: Can GCS cause dependency or withdrawal symptoms?

Regulatory sources confirm that GCS, which is a mineral and vitamin supplement, is not documented to cause physical dependence. Therefore, the medication does not require a specific tapering schedule upon discontinuation.

Q: Why do people mention GCS in connection with [unrelated condition, e.g., joint pain]?

GCS is intended to correct calcium and Vitamin D deficiency. Official health information often notes that deficiency in Vitamin D may be associated with non-specific symptoms such as joint pains or generalized fatigue, which may be why the medication is mentioned in connection with these issues.

Q: What warnings are included on the GCS label regarding alcohol consumption?

Regulatory guidance often includes a general health warning to moderate alcohol intake. This caution relates to the Colecalciferol component, as excessive alcohol consumption may interfere with the liver's ability to properly metabolize Vitamin D.

Q: Can GCS cause stomach problems?

Yes. According to regulatory-linked patient information, common gastrointestinal side effects can include stomach upset, constipation, or mild stomach pain.

Q: Does GCS affect mood or behavior?

Mood or behavioral changes are not listed as a primary adverse effect. However, some studies indicate that a Vitamin D deficiency state itself is associated with symptoms like depression and cognitive impairment, a state which the medication is intended to correct.

Q: Can GCS interact with herbal remedies?

The official interaction profile only lists pharmaceutical agents. However, patient safety materials contain general guidance that all herbal supplements, non-prescription products, and vitamins should be disclosed to a healthcare provider.

Q: Does GCS have a black box warning?

No. GCS is a mineral and vitamin supplement and does not carry a Black Box Warning in its official regulatory labeling. This is the highest level of safety caution cited by the FDA.

Q: Does GCS affect vision?

Vision loss is not listed as an adverse effect in the official safety profile. It is known that Vitamin D and calcium levels play a biological role in ocular health, and deficiency states have been the subject of research concerning eye conditions.

Q: What are the restrictions on driving or operating machinery while using GCS?

Official regulatory sources for the ingredients in GCS generally indicate that the medicine is not expected to impair a person's ability to safely drive or operate heavy machinery.

Q: What are the most common reasons GCS might be stopped?

Official regulatory information requires that the use of GCS be stopped if a contraindication, such as hypercalcaemia or the development of kidney stones, occurs. Additionally, the medication is often discontinued once the underlying nutritional deficiency state has been corrected.

Q: Are there different brand names for the same GCS compound?

The active ingredients in GCS—Calcium Citrate Malate and Colecalciferol—are common in the supplement market. Therefore, the same compound may be available under various different brand names, depending on the manufacturer and the market.

Q: Does GCS change the effectiveness of birth control?

The official drug interaction profile for GCS does not list hormonal contraceptives (birth control pills) as agents that have a known clinically significant interaction that would change their effectiveness.

Q: What should I do if a family member accidentally takes GCS?

Official product information advises that in the event of an accidental or excessive dose (overdose) of GCS, immediate contact with a poison control center or seeking emergency medical attention is required due to the risk of severe hypercalcaemia.

How should GCS be stored and disposed of?

How to Store and Dispose of GCS (Calcium Citrate Malate/Colecalciferol)

The storage and disposal of GCS must strictly follow the official instructions to maintain product stability and ensure safety. Storage requires keeping the tablets at controlled room temperature, generally below 25 C, and protecting them from excess heat and moisture.


The product must be kept in its original container with the lid tightly closed to protect the sensitive Colecalciferol component from light. All medication must be stored out of the sight and reach of children.

Disposal of unused or expired GCS should primarily utilize a community drug take-back program. If one is unavailable, the medication should be mixed with an unappealing substance, placed in a sealed bag, and discarded in the household trash, with all personal information removed from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of GCS found in:

A-Z Index: